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Pneumonia is a common manifestation of the potentially fatal disease melioidosis, caused
by the select agent bacteria Burkholderia pseudomallei. In this study we describe a
new model system to investigate pulmonary melioidosis in vivo using bioluminescent-
engineered bacteria in a murine respiratory disease model. Studies were performed to
validate that the stable, light producing B. pseudomallei strain JW280 constitutively pro-
duced light in biologically relevant host–pathogen interactions. Hairless outbred SKH1mice
were used to enhance the ability to monitor B. pseudomallei respiratory disease, and were
found to be similarly susceptible to respiratorymelioidosis as BALB/cmice.This represents
the ﬁrst demonstration of in vivo diagnostic imaging of pulmonary melioidosis permitting
the detection of B. pseudomallei less than 24 h post-infection. Diagnostic imaging of pul-
monary melioidosis revealed distinct temporal patterns of bacterial colonization unique to
both BALB/c and SKH1 mice. Validation of these model systems included the use of the
previously characterized capsule mutant, which was found to colonize the upper respira-
tory tract at signiﬁcantly higher levels than the wild type strain.These model systems allow
for high resolution detection of bacterial pulmonary disease which will facilitate studies of
therapeutics and basic science evaluation of melioidosis.
Keywords: bioluminescent diagnostic imaging, hairless mousemodel, upper respiratory tract infection, pulmonary
disease, Burkholderia pseudomallei, melioidosis, capsular polysaccharide, intranasal infection
INTRODUCTION
Burkholderia pseudomallei is a Gram-negative bacterial pathogen
responsible for the potentially fatal disease melioidosis.
B. pseudomalleihasnaturally developed the resistance tonumerous
classes of antibiotics, and presently there is no licensed vaccine for
immunoprotection. Susceptible hosts acquire melioidosis through
several possible routes of infection including ingestion, percuta-
neous inoculation, and inhalation (Currie et al., 2000; Inglis et al.,
2000). The potential for respiratory acquisition of fatal melioi-
dosis from a bioweapon has contributed to the identiﬁcation of
B. pseudomallei as a category B Select Agent organism (Rotz et al.,
2002).
The lung is the most commonly affected organ in human
melioidosis (Wiersinga et al., 2006), and radiological imaging
approaches have identiﬁed the liver and spleen as additional key
sites of infection (Muttarak et al., 2008; Lim and Chong, 2010).
Mice have been used as an excellent surrogate model which allow
for studies of bacterial colonization at all major sites of infection,
including the lung, liver, and spleen, approximating numerous
aspects of clinical melioidosis (Warawa, 2010). Dissemination and
progression of disease in the lung are poorly characterized phe-
nomena in both clinical melioidosis and the mouse model due
to the lack of diagnostic tools to monitor disease progression.
Bioluminescently engineered B. pseudomallei were recently used
to study respiratory melioidosis in mice, in which in vivo detection
of bacteria was limited to the upper respiratory tract (URT) with
no bioluminescent detection of pulmonary disease (Owen et al.,
2009). In the same study, ex vivo bioluminescence was detected
additionally in the liver, spleen, and NALT in euthanized ani-
mals. A goal of this current study was to establish the ability
to detect bacterial colonization of the lung in vivo, early in the
infectious process, in order to facilitate both therapeutic and basic
science investigations of mechanisms of virulence employed by
B. pseudomallei.
Several virulence determinants have been identiﬁed as critical
to the virulence of B. pseudomallei in animal models including
Type 3 Secretion, Type 6 Secretion, LPS, and capsular polysaccha-
ride (CPS I; Deshazer et al., 1998; Reckseidler et al., 2001; Atkins
et al., 2002; Stevens et al., 2004;Warawa andWoods, 2005; Burtnick
et al., 2011). Of these, all but LPS have been additionally demon-
strated to be important for murine respiratory melioidosis (Pilatz
et al., 2006;Warawa et al., 2009). We have previously characterized
the role of the capsular polysaccharide in respiratory disease and
found that a capsule operon mutant is attenuated 101.8 fold and
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facilitates efﬁcient initial pulmonary colonization, but that capsule
is not critically required for dissemination of B. pseudomallei to
the liver and spleen (Warawa et al., 2009). In developing the abil-
ity to perform diagnostic imaging of respiratory melioidosis, we
included use of the capsular polysaccharide mutant to attempt
to further characterize the role for this virulence determinant in
pulmonary disease.
MATERIALS AND METHODS
BACTERIAL STRAINS AND MEDIA
All strains, plasmids, and oligonucleotides are summarized in
Table 1. Luria broth (LB; Lennox, 1955) or trypticase soy broth
(dialyzed and chelated) (TSBDC; Brett et al., 1997) were used
to culture B. pseudomallei strains at 37˚C with shaking. E. coli
strain TOP10 was used for cloning purposes. Antibiotics were
used at the following concentrations: kanamycin (Km: 25μg/ml),
streptomycin (Sm: 100μg/ml), gentamicin (Gm: 20μg/ml), and
polymyxin B (Pm: 50μg/ml).
CHROMOSOMAL INTRODUCTION OF LUX OPERON
The cloning site of pGSV3-lux was modiﬁed to allow for direc-
tional cloning of DNA fragments upstream of the luxCDABE
operon. A 850-bp fragment was ampliﬁed by PCR from pGSV3-
lux [pGSV4 ApaI(+)/luxCAatII(−)] and cloned into pCR4. This
fragment was excised from pCR4 using EcoRI/Aat II, and cloned
into the same restriction sites of pGSV3-lux to yield pGSV4.
Subsequently, two PCR fragments from the B. pseudomallei
genome [5′ara EcoRI(+)/5′ara ApaI(−) and 3′ara NotI(+)/3′ara
SpeI(−)] were cloned into pGSV4 as EcoRI/ApaI (812 bp) and
Not I/SpeI (867 bp) fragments to yield pGSV7. The tolC pro-
moter was PCR ampliﬁed from B. pseudomallei genomic DNA
[PtolC(+)/PtolC(−)] and cloned into pGSV7 as an NheI/BamHI
fragment. A 7.6-kb EcoRI/KpnI fragment was excised from
pGSV7-PtolC and cloned into the same sites of pKAS46 to yield
pKAS46-araPtolC-lux, which was transformed into the E. coli
strain S17-1. S17-1/ pKAS46-araPtolC-lux was conjugated with
B. pseudomallei strains for the insertion of the PtolC-lux con-
struct into the ancestrally deleted arabinose utilization operon in
an allelic exchange protocol described elsewhere (Warawa et al.,
2009). The DD503::PtolC-lux strain was named JW280, and the
capsule mutant JW270::PtolC-lux strain was named JW280wcb.
Strains JW280 and JW280wcb were identiﬁed by their ability
to produce light, their resistance to streptomycin, and sensitivity
to kanamycin.
INFECTION OF CULTURED CELLS
J774A.1 cells were maintained in DMEM supplemented with 10%
heat inactivated fetal bovine serum (Invitrogen) and grown at
37˚C with 5% CO2. For infection studies, J774A.1 cells were
seeded at 7.5× 104 cells per well (100μl) in a white 96-well
plate (Greiner Bio-One) 1 day before infection. B. pseudoma-
llei strains were subcultured 1:25 (v/v) from an LB overnight
culture into TSBDC and grown at 37˚C with shaking for 3 h.
The bacterial concentration was estimated from OD600 measure-
ments, bacterial suspensions were appropriately diluted into PBS,
and a 5-μl aliquot of B. pseudomallei suspension was used to
inoculate each well of J774A.1 cells. Four replicate plates were
infected with B. pseudomallei strains JW280 and JW280wcb and
Table 1 | Bacterial strains, plasmids and oligonucleotides.
Strain Genotype/description Source
DD503 B. pseudomallei 1026b
derivative, PmR, SmR, AGS,
TcS
Moore et al. (1999)
JW270 B. pseudomallei wcb Warawa et al. (2009)
JW280 B. pseudomallei
DD503::PtolC -lux
This study
JW280wcb B. pseudomallei
JW270::PtolC -lux
This study
TOP10 Chemically competent
E. coli cloning strain
Invitrogen
S17-1 E. coli strain for conjugation Simon et al. (1983)
Plasmid
pKAS46 Suicide vector
Skorupski and Taylor
(1996)
pGSV3-lux Promoterless lux reporter
construct
Moore et al. (2004)
pGSV4 Promoterless lux reporter
construct, directional MCS
This study
pGSV7 pGSV4 with
B. pseudomallei arabinose
operon fragments
This study
pGSV7-PtolC PtolC driven lux expression This study
pKAS46-araPtolC -lux Suicide vector harboring
PtolC -lux
This study
Oligonucleotide Sequence (5′ → 3′)
pGSV4 ApaI(+) GGGCCCACTCGAGGTAAAATGGATGGCAAATATG
ACTAAAAAAATTTC
luxC AatII(−) GCACCTGTCGCTGCGGACGTCAAATCAACAGGAT
TATCGA
5′ara EcoRI(+) GTGGAATTCTCCCGCGCGGCATCGCGAATCGCCTC
5′ara ApaI(−) GAGGGCCCATCAGGATCCGAGGCTAGCTAGCCCG
CGCACGACTTCCATCG
3′ara NotI(+) GCACGCGGCCGCGGATCGTTCGTCGGTATTTCG
TTTC
3′ara SpeI(−) GCCACTAGTGCGCGCCTTCGATGGGTACCCAGTA
CAGCGCGTG
PtolC(+) GCGATTGCTAGCCGGAATCAGGCTATCATGCACTC
AAGTTGG
PtolC(−) GGTGGATCCAGGATCGTCAAAAACCGATATAAGAC
GGGACCG
treated with gentamicin (20μg/ml ﬁnal) 1 h after infection. Lux
measurements were taken (Victor, Perkin Elmer) from one of
the replicate plates at either 3, 5, 7, or 9 h post-infection, then
immediately samples were processed for plate enumerations by
removing the media, lysing the samples in 0.1% Triton X-100
for 5 min, serially diluting samples in PBS, and enumerating on
LB plates.
ANIMAL INFECTIONS – SURVIVAL CHALLENGE
Murine infection studies were conducted at BSL-3 conﬁnement
and were approved by the Rocky Mountain Laboratories Biosafety
andAnimalCare andUseCommittees in accordancewithNational
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Institutes of Health guidelines. Intranasal (i.n.) infection of groups
of six 8-week-old female BALB/c mice (Charles River Labora-
tories) was carried out as previously described (Warawa et al.,
2009),using lux+B. pseudomallei strains JW280 and JW280wcb.
Animals were euthanized at the onset of terminal disease symp-
toms, thus 50% infectious dose (ID50) values were calculated as
opposed to death endpoint based lethal dose (LD50) values. Sta-
tistical analysis of survival data was conducted using GraphPad
Prism 5 to evaluate signiﬁcant differences in survival curves by
log-rank (Mantel–Cox) test. StatPlus 2008 was used to perform
ProbitAnalysis to estimate ID50 values for JW280 and JW280wcb
in the SKH1 model.
HISTOLOGICAL ANALYSIS OF INFECTED TISSUE
Tissues were harvested from animals involved in the survival stud-
ies. Tissues were ﬁxed in formalin, processed and stained with
hematoxylin and eosin (H&E), and the histopathology of lung,
liver, and spleen was scored as previously described (Warawa et al.,
2009).
TIME COURSE LUX IMAGING
Groups of six BALB/c and SKH1 female 8-week-old mice (Charles
River Laboratories) were infected i.n. with 30μl of PBS bacterial
suspension containing either 1× 104 CFU JW280 or 1× 106 CFU
JW280wcb. BALB/c mice were shaved to reduce the amount
of fur covering their dorsal thoracic cavities. Mice were anes-
thetized with 2.5% isoﬂurane and imaged at∼12 h intervals, with
5 min exposures from the dorsal perspective using an IVIS Lumina
(Caliper Life Sciences). Measurements of lung-speciﬁc lux activity
were taken by selecting regions of interest (ROI; Living Image
3.0, Caliper Life Sciences) of the dorsally viewed chest cavity
and area-normalized backgrounds were subtracted. Animals were
euthanized at ﬁrst presentation of terminal disease symptoms,
and lungs were harvested for bacterial enumeration, as described
previously (Warawa et al., 2009).
DATA PRESENTATION AND STATISTICAL ANALYSIS
Unless otherwise stated, Graph Pad Prism 5 was used to plot data
and conduct statistical analysis by unpaired Student’s t -test.
RESULTS
GENERATING LUX + B. PSEUDOMALLEI STRAINS
We sought to engineer a strain of B. pseudomallei which con-
stitutively and stably produced light from the Photorhabdus
luminescens luxCDABE operon. To ensure stability of the lux
operon in the absence of antibiotic selection, the operon was
introduced into the chromosome by allelic exchange. The inser-
tion site chosen for insertion of the lux operon was the site
of an ancestrally deleted arabinose utilization operon, known
to be present in B. thailandensis while only gene fragments are
present in the B. pseudomallei genome (Moore et al., 2004). Sev-
eral promoters were evaluated for their ability to constitutively
produce light under a variety of growth conditions. One such
promoter, PtolC, was previously demonstrated to constitutively
produce high level photon emission in Pseudomonas aeruginosa
(Kadurugamuwa et al., 2003). Therefore, the PtolC-lux construct
was introduced into the genomeof wild typeB. pseudomallei strain
DD503 to generate a stable Lux-expressing strain JW280. Simi-
larly, the previously characterized capsular polysaccharide operon
mutant, JW270,was engineered to produce light resulting in strain
JW280wcb.
INTRACELLULAR SURVIVAL OF LUX-EXPRESSING B. PSEUDOMALLEI
To investigate whether the light production from JW280 and
JW280wcb correlates with bacterial numbers, B. pseudomallei
strains were examined in a cell culture model system. It has
been reported that B. pseudomallei survive within cultured
macrophages, escape from the phagosome in a type III secretion-
dependent mechanism, and replicate in the cytoplasm (Stevens
et al., 2002). The capsular polysaccharide was previously found to
not be critical for intracellular survival of B. pseudomallei at early
time points (Warawa et al., 2009),however capsulemutantsmay be
required for prolonged survival within macrophages (Wikraiphat
et al., 2009).In a gentamicin protection assay, light producing
B. pseudomallei strains JW280 and JW280wcb were found to
infect J774A.1 macrophages and proliferate as previously reported
(Figure 1A). No signiﬁcant difference in growth was observed
between wild type and capsule mutant at 3, 5, or 7 h post-
infection. However, at 9 h post-infection the capsule mutant had
fewer organisms in infected J774A.1 macrophages than wild type.
FIGURE 1 | Intracellular survival of B. pseudomallei in J774A.1 cell line.
B. pseudomallei strains JW280 and JW280wcb were used to infect
7.5× 104 J774A.1 murine macrophages in triplicate at an MOI of 0.5. After 1 h,
extracellular bacteria were killed with gentamicin. At time points of 3, 5, 7, and
9 h post-inoculation, the light production of triplicate set of samples was
measured, then samples were lysed with 0.1%Triton X-100 and enumerated
by plate counting. The CFU/well was plotted as a function of time for both
JW280 and JW280wcb (A). Similarly both CFU/well (left y -axis) and
cps/well (right y -axis) were jointly plotted as a function of time for JW280 (B)
and JW280wcb (C). The mean and standard deviation were plotted for each
strain/time point. Asterisks indicate signiﬁcant difference in bacterial
colonization of J774A.1 cells at speciﬁc time points (*p < 0.05).
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This was consistent with previous reports which suggested that
the capsule mutant was not as ﬁt as wild type bacteria during
late stage infection of macrophages (Wikraiphat et al., 2009). Bio-
luminescence was measured by plate reader immediately before
harvesting samples for bacterial enumeration (counts per second,
cps). Changes in both bacterial number and emitted photons were
plotted as a function of time for both wild type JW280 (Figure 1B)
and the capsulemutant (Figure 1C). Both JW280 and JW280wcb
produced light consistent with bacterial number from 3 to 7 h
post-infection with an average cps/CFU ratio of 2.79 × 10−4 and
3.02× 10−4, respectively. At 9 h post-infection, relative light pro-
duction increased with JW280 and JW280wcb ratios calculated
to be 3.07× 10−4 and 4.49× 10−4 cps/CFU, respectively. Thus,
both JW280 and JW280wcb produce light constitutively during
host–pathogen interaction studies, with the potential for varia-
tions in the cps/CFU ratio based on bacterial ﬁtness during these
interactions.
SKH1 MOUSE SUSCEPTIBILITY TO MELIOIDOSIS
We have previously demonstrated that a B. pseudomallei cap-
sule mutant is attenuated 101.8 fold when introduced by the i.n.
route in the BALB/c mouse model (Warawa et al., 2009). Using
both wild type and capsule mutant strains of B. pseudomallei,
we examined whether the SKH1 mouse strain represents a viable
model for the study of respiratory melioidosis, and whether
Lux-producing strains of B. pseudomallei are attenuated. SKH1
mice are an immunocompetent hairless strain that potentially
permit enhanced bioluminescent detection due to their lack of
fur. A pairwise comparison of lux− and lux+ versions of both
wild type (DD503 and JW280) and capsule mutant (JW270 and
JW280wcb) strains were not signiﬁcantly different in their vir-
ulence in BALB/c mice (Figure 2A, DD503 and JW270 survival
curves reproduced as per Warawa et al., 2009). This ﬁnding
indicates that introduction of the luxCDABE operon into the
B. pseudomallei genome did not signiﬁcantly impact its viru-
lence in a characterized disease model. The Lux-producing wild
type and capsule mutant strains were next used to compare the
susceptibility of the SKH1 mouse line to melioidosis relative to
the previously characterized BALB/c mouse line. Both SKH1 and
BALB/c mice were similarly susceptible to respiratory melioidosis
when infected with the wild type strain (Figure 2B, left panel).
Interestingly, SKH1 mice were more resistant to infection with
the capsule mutant than BALB/c mice (Figure 2B, right panel),
suggesting that greater resolution may be observed in the SKH1
model when evaluating attenuation of bacterial strains or poten-
tially when studying therapeutic interventions. A dose response
evaluation of wild type and capsule mutant strains was next con-
ducted in SKH1 mice to facilitate estimation of the 50% ID50
values. Probit analysis of the survival curve data (Figure 2C) was
used to estimate an ID50 of 2.47× 103 CFU (95% CI: 3.5× 102
to 1.72× 104 CFU) for JW280 and 5.23 × 105 CFU (95% CI:
2.47× 105 to 1.11× 106 CFU) for JW280wcb. It is noteworthy
that infection with 107 CFU of JW280wcb produced rapid mor-
bidity suggestive of endotoxicity rather than disease, where the
ID50 of JW280wcb may be higher than estimated. Thus, the
capsule mutant is attenuated greater than 200-fold in the SKH1
model.
Infected SKH1 tissues were harvested for evaluation of
histopathological damage. As previously reported in the BALB/c
model (Warawa et al., 2009),both thewild type and capsulemutant
strains produce signiﬁcant pathology in the lung and liver at the
moribund stage of disease (Figure 3). Extensive lesions are present
throughout the lung associated with inﬂammatory cell recruit-
ment, ﬁbrin deposition, and cellular necrosis. The liver pathology
was characterizedbymultifocal lesions, and as previously reported,
the capsule mutant was found to induce fewer and smaller lesions.
Pathology was also detected in the nasal cavity (rhinitis), middle
ear (otitis media), and brain (meningitis; data not shown). Blind
scoring of the tissue histopathology was conducted to conﬁrm that
the capsule mutant indeed produced signiﬁcantly reduced hepatic
damage (Figure 4). It was noted, however, that neither the wild
type nor capsule mutant strains induced signiﬁcant pathology in
the spleen. This is in contrast to our previous ﬁnding of wild type,
but not capsule mutant, pathology being detected in the spleen of
BALB/c mice. This suggests that B. pseudomallei may not colonize
the spleen of SKH1 to the same extent as in BALB/c mice, or that
the response to B. pseudomallei in the spleen of SKH1 is altered
from the response in BALB/c mice.
IN VIVO DETECTION OF RESPIRATORY TRACT B. PSEUDOMALLEI
INFECTION
In order to investigate the potential for in vivo diagnostic imag-
ing using bioluminescent B. pseudomallei, SKH1 and BALB/c
mice were infected i.n. with 104 CFU of JW280 or 106 CFU of
JW280wcb, and time course in vivo imagingwas conducted.Mice
were euthanized at the onset of moribund disease and lung, liver,
and spleen tissues were collected to enumerate bacterial coloniza-
tion at key sites of infection. Both the SKH1 and BALB/c mice
in the moribund stage of melioidosis were found to be colonized
at similar levels by both wild type and capsule mutant strains of
B. pseudomallei, with the exception that there were signiﬁcantly
fewer JW280 detected in the late stage infected lung of BALB/c
mice relative to SKH1 mice with a 2.5-fold difference in average
bacterial colonization (Figure 5). It was noted that the spleen of
SKH1 mice was colonized at a similar level as the spleen of BALB/c
mice, suggesting that bacterial colonization does not account for
the lack of splenic pathology in SKH1 mice (Figure 4). It was
also determined that the lung is the most signiﬁcantly colonized
organ in SKH1 infected mice with an average 104.2 fold more
B. pseudomallei in the lung than the liver, and 105.4 fold more
B. pseudomallei in the lung than the spleen. In BALB/c mice, the
average colonization ratios are 102.8 fold lung to liver and 104.7
fold lung to spleen.
Images of bioluminescence detection from in vivo diagnostic
imaging were collected using an IVIS Lumina system. Figure 6
presents a representative collection of images demonstrating the
potential to track developing pulmonary infection in mice over
numerous time points in individual mice, where the last image of
each panel represents moribund disease. In both mouse models
and using both B. pseudomallei strains, in vivo detection of pul-
monary infection was successfully achieved. Consistent with the
bacterial enumeration data, less light emission is detected in the
lung of JW280-infected BALB/c mice at moribund disease relative
to JW280 infection of SKH1 mice.
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FIGURE 2 |Virulence of Lux-producing B. pseudomallei strains.
Groups of six mice were infected by the i.n. route with B. pseudomallei
and monitored for 14 days. (A) Groups of BALB/c mice were infected
with 105 CFU of wild type strains DD503 (lux−) or JW280 (lux+, left
panel) or with 106 CFU of capsule mutant strains JW270 (lux−) or
JW280wcb (lux+, right panel). (B) Groups of SKH1 or BALB/c mice
were infected with 105 CFU of JW280 (left panel) or 106 CFU
JW280wcb (right panel) to compare the susceptibility of each mouse
strain to melioidosis. (C) SKH1 mice were infected with 3- to 10-fold
serial dilutions of JW280 (103–105 CFU, left panel) or JW280wcb
(105–107 CFU, right panel) to facilitate estimation of the ID50 for each strain.
Mice were euthanized at the onset of moribund disease. Asterisks indicate
signiﬁcant differences between survival curves using the log-rank
(Mantel–Cox) test.
Photon emission was quantiﬁed from both the URT and dorsal
thoracic cavity in all imaged mice beginning 24 h post-infection.
An analysis of the correlation between total emitted light (total
ﬂux) from the thoracic cavity and bacterial colonization of the
lung was performed. Trend lines were constrained through the
y-axis at the level of noise estimated from mock-infected animals.
It was determined that BALB/c mice have a much higher level of
noise (2.6± 0.7× 104 p/s) than SKH1 mice (3.1± 2.1× 103 p/s;
∗∗p = 0.0064), which was subsequently found to relate to the
amount of residual fur present on BALB/c mice (data not shown).
In both the BALB/c and SKH1 mouse models, the capsule mutant
produced greater light per CFU than the wild type strain in the
lung (Figure 7A) as previously observed in cell culture assays
(Figure 1), suggesting that the capsulemutantmaybe experiencing
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FIGURE 3 | Histological analysis of B. pseudomallei -infected tissues.
Photomicrographs of representative tissue samples from SKH1 mice infected
i.n. with JW280 (104 CFU), JW280wcb (106 CFU), or PBS mock-infected
control animals. Samples were formalin-ﬁxed, stained with hematoxylin and
eosin (H&E), and imaged by bright ﬁeld microscopy using either a ×10 (lung)
or ×20 (liver) objectives.
a similar environment in vivo as that modeled in cultured murine
macrophages. Using the calculated equations of the trend lines,
it was estimated that the level of detection of wild type and cap-
sule mutant bacteria in the lung of SKH1 mice is 5.7 × 106 and
2.1× 106 CFU, respectively, at one standard deviation of noise
above the average level of noise. Similarly, the BALB/c detection
levels were estimated to be 2.6 × 107 and 4.4× 106 CFU for the
wild type and capsule mutant strains, respectively.
The total ﬂuxwas also plotted as a function of time forwild type
and capsule mutant infections of BALB/c (Figure 7B) and SKH1
(Figure 7C) mice, and the noise level indicated in each plot. The
ability to sensitively detect photon emission fromBALB/cmicewas
reduced relative to SKH1 mice, with temporal plots of total ﬂux
often overlapping the estimated noise level (Figure 7B, horizontal
bar). In the BALB/cmodel, both thewild type and capsulemutants
exhibited a biphasic expansion in the lung characterized by an
initial increase in pulmonary bacterial burden until approximately
40 h post-infection, followed by a decrease in lung-associated
bacteria and subsequent second phase expansion beginning at
approximately 60 h post-infection (Figure 7B).
In the hairless SKH1 model, the low noise (Figure 7C, x-axis)
allows for sensitive detection of both wild type and capsule mutant
bacteria at 24 h post-infection, with the potential for detection at
much earlier time points. Unlike the BALB/c model, a biphasic
expansion is not observed, and instead both wild type and capsule
mutant strains B. pseudomallei exhibit an initial lag phase prior
to logarithmic expansion in the lung (Figure 7C). Of the four
wild type-infected SKH1 mice which became morbidly infected,
one mouse had two drops in bacterial colonization before the
onset of late stage disease, indicating that individual-to-individual
alterations in disease kinetics can be detected using this system.
The wild type and capsule mutant strains are associated with an
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FIGURE 4 | Histopathological scoring of SKH1 infected tissue. Lung,
liver, and spleen from SKH1 mice infected i.n. with JW280 (104 CFU) or
JW280wcb (106 CFU) were ﬁxed, stained with H&E, and scored in a blind
study for varying degrees of pathology. The scoring system was deﬁned as:
0=within normal limits, 1=minimal, 2=mild, 3=moderate, 4= severe.
Individual data points, the mean, and standard deviation are plotted, and
statistically signiﬁcant variation from JW280-infected tissue scoring is
indicated by asterisks (*p < 0.05).
initial low rate expansion in the lung until a titer of approximately
3.2× 104 organisms is achieved, at which point rapid exponen-
tial increase is observed. Statistical analysis was conducted on
parsed data sets representing early and late stage expansion for
both strains, and slopes from logarithmically transformed data
were signiﬁcantly different when comparing early to late stage col-
onization rates for each strain, but no intra-strain differences were
statistically signiﬁcant (data not shown).
Mice that survived the pneumonia phase of infection (ﬁrst
5 days) were also evaluated for ﬂuctuations in total ﬂux as a func-
tion of time (Figure 7D). These mice were characterized as having
oscillatory changes in total ﬂux throughout the imaging conducted
to day 6. Wild type-infected total ﬂux plots trended downward
from 100 h post-infection, which was consistent with the inability
to culture organisms from the lung at the termination of the exper-
iment at 14 days post-infection. In contrast, the oscillating total
ﬂux of the capsule mutant survivors (Figure 7D, right panel)
trended upward, and at 14 days post-infection, a bacterial bur-
den of 9.5× 103 (±1.52× 103) CFU/lung was observed. This data
suggests that the capsule mutant potentially establishes a chronic
infection in SKH1 mice while survivors of wild type infection
effectively clear B. pseudomallei.
A striking feature of the bioluminescence overlay images is the
observation of signiﬁcant colonization of theURT as a result of i.n.
infection (Figure 6), as observed previously (Owen et al., 2009).
An evaluation of the ratio of nasal cavity total ﬂux was conducted
as a function of the level of thoracic cavity total ﬂux in order to
estimate the fold increase in number of B. pseudomallei associated
preferentially with the nasal cavity. This analysis made use of mice
that develop lethal pneumonia and therefore achieve high titers of
B. pseudomallei in the lung. At all measured time points, the ratio
of nasal cavity ﬂux to thoracic cavity ﬂux was included to account
for temporal ﬂuctuations. In both the SKH1 and BALB/c models,
the capsule mutant had a signiﬁcantly higher proportion of bacte-
ria associated with the URT with an average of 4.5-fold higher ﬂux
in SKH1 mice and 3.1-fold higher ﬂux in BALB/c mice (Figure 8).
These data indicate that the capsule mutant colonizes the nasal
cavity at a signiﬁcantly higher level than wild type B. pseudomallei.
DISCUSSION
This study focused on characterizing and validating a diagnostic
imaging model for investigating respiratory melioidosis in mouse
models. The approach we selected was use of optical imaging
strategies usingB. pseudomallei strains engineered to constitutively
produce bioluminescence. Bioluminescence offers the advantage
over ﬂuorescent for detection of weak signals due to the enzymatic
ampliﬁcation of signal, and bioluminescence offers the added ben-
eﬁt of detecting only metabolically active bacteria as the produc-
tion of light requires energy from the cell. The luxCDABE operon
from P. luminescens allows for light production in the absence of
addition of foreign substrates. This is in contrast to the eukary-
otic luciferases which require exogenous addition of D-luciferin.
FIGURE 5 | B. pseudomallei colonization of key sites of infection. SKH1 and BALB/c mice infected i.n. with JW280 (104 CFU) or JW280wcb (106 CFU)
were euthanized at the onset of morbid disease symptoms, organs were harvested, homogenized in PBS and bacteria were enumerated. Data indicates the
total number of bacteria detected per organ for lung (A), liver (B), and spleen (C). Signiﬁcant difference between data sets indicated by asterisk (*p < 0.05).
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FIGURE 6 | In vivo detection of a developing B. pseudomallei infection. Overlay images captured with an IVIS Lumina system of representative SKH1 and
BALB/c mice infected i.n. with JW280 (104 CFU) or JW280wcb (106 CFU). Infected mice were imaged twice daily and images from late infection (54–92 h) are
presented until the time point at which mice were euthanized due to terminal disease. All images were normalized to the same photon saturation scale.
We preferentially selected use of the lux operon as B. pseudomallei
are known to trafﬁc in intracellular environments in vivo, and
the lux operon allows for stable access to endogenous luciferase
substrate using the accessory luxCDE gene products. The same
luxCDABE operon was previously introduced by transposon into
B. pseudomallei strain 08, where i.n. infections of mice resulted
in vivo detection bacteria only in the URT, with ex vivo analy-
sis demonstrating bioluminescence of the liver, spleen, and NALT
(Owen et al., 2009). The authors do not comment on the absence
of morbid disease when infecting with 3.6 × 105 organisms, how-
ever we hypothesize that the small delivery volume (12μl) may
have contributed to a minimal pulmonary infection, and simi-
larly the low bacterial burden reported in the lung (Owen et al.,
2009). Thus, B. pseudomallei strain 08 may represent a low viru-
lence strain, or may indicate that infections limited to the URT do
not lead to morbid disease due to the importance of the lung in
B. pseudomallei virulence. However, our current model has been
shown to facilitate sensitive detection of virulent B. pseudomallei
in cell culture and mouse disease models, allowing for ratiometric
detection of changes in bacterial burdens in vivo.
The bioluminescent strain of B. pseudomallei engineered in
this study, JW280, was found to maintain an excellent correlation
between bacterial number and photon production in a biologi-
cally relevant macrophage cell culture model. Furthermore, stable,
chromosomal introduction of the lux operon was not found to
signiﬁcantly attenuate B. pseudomallei virulence. Both wild type
and capsule mutant B. pseudomallei strains maintained a close
relationship between measured cps and CFU for the majority of
time points investigated in macrophage survival assays. At a late
time point, the capsule mutant was found to proliferate less efﬁ-
ciently than wild type in J774A.1 cells, and this reduction in ﬁtness
was associated with an increase in relative light production. Inter-
estingly, the relative light production of the capsule mutant in
the mouse lung was similarly higher than the wild type strain in
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FIGURE 7 | Dynamic assessment of lung colonization by B. pseudomallei.
SKH1 and BALB/c mice were infected i.n. with JW280 (104 CFU),
JW280wcb (106 CFU) or PBS mock-infected, and mice were imaged dorsally
with an IVIS Lumina system beginning 24 h post-infection. Living Image 3.0
software was used to enumerate light emission from the lung. PBS
mock-infected mice were used to establish baseline noise. At onset of morbid
disease, mice were euthanized and bacteria enumerated from the lung. (A)
Plot of emitted light immediately before euthanization of mice in morbid
disease stage as a function of bacterial burden in the lung. The y -intercept of
the trend line was constrained through the estimated noise determined from
mock-infected mice. (B,C)Total ﬂux plotted as a function of time for mice
which developed morbid disease in BALB/c (B) and SKH1 (C) mice. The
average noise level estimated from mock-infected mice is indicated with a
horizontal bar (B) or the x -axis (C). (D)Total ﬂux plotted as a function of time
for mice which survived the pneumonia phase of disease in SKH1 mice. The
average noise level estimated from mock-infected mice is set at the x -axis.
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FIGURE 8 | Preferential colonization of the nasal cavity by
B. pseudomallei. SKH1 and BALB/c mice were infected i.n. with JW280
(104 CFU) or JW280wcb (106 CFU) and mice were imaged dorsally with an
IVIS Lumina system beginning 24 h post-infection. The background
corrected nasal cavity to thoracic cavity ratio was evaluated at all time
points for mice that developed lethal pneumonia. The collective of all
experimental ratios were plotted for each group. Signiﬁcant differences
between groups are indicated by asterisks (**p < 0.01, ***p < 0.001).
both BALB/c and SKH1 mice. Prolonged incubation of a capsule
mutant in cultured macrophages was previously reported to be
associated with a decrease in capsule mutant viability (Wikraiphat
et al., 2009), and the data from this current study suggests that the
same mechanism affecting capsule mutant viability in cell culture
models may be exerted in vivo during pulmonary disease.
This study represents the ﬁrst characterization of SKH1 mice
to investigate melioidosis. SKH1 mice are a hairless mouse model
useful for studying a variety of dermatologically important events
such as burn models, UV sensitivity, skin aging, and also offer
the ability to enhance optical diagnostic imaging for both biolu-
minescent and ﬂuorescence detection strategies (Benavides et al.,
2009). The effect of fur on masking photon emission has been
previously estimated to account for up to a 10-fold loss in signal
in ﬂuorescence imaging approaches (Nishijo et al., 2009). In this
present study, we found that fur also contributes to the noise level
which also affects sensitivity of detection, where shaved BALB/c
mice have a greater than eight-fold higher noise level than SKH1
mice. Shaving was performed in preference to use of depilatory
creams as it has been reported that depilatory creams allow for
complete hair regrowth over a 14-day period while shaving results
in much slower hair regrowth (Faia et al., 2008).
Unlike nude mice, hairless SKH1 are considered to be an
immunocompetent mouse strain which we hypothesized would
represent an excellent new model for bioluminescent-based diag-
nostic imaging of melioidosis. In this study, outbred SKH1 were
found to be similarly sensitive to respiratory melioidosis as inbred
BALB/c mice. Interestingly, SKH1 mice were found to be more
resistant to the virulence of the capsule mutant, such that the cap-
sule mutant attenuation was higher in the SKH1 mouse model
than we previously reported in the BALB/c model. Thus, SKH1
mice may allow for higher resolution determination of attenua-
tion when investigating roles of bacterial virulence determinants.
We have also demonstrated that SKH1 mice provide a beneﬁt over
BALB/c mice in that they: (i) do not have to be shaved, (ii) have
no residual fur to mask photon emission or create noise, and (iii)
allow for higher levels of lung colonization of wild type B. pseudo-
mallei. Themost signiﬁcant caveatwe observed in the SKH1model
is the lack of splenic pathology when infected with wild type B.
pseudomallei even though the bacterial burden in SKH1 mice is
similar to that of BALB/c mice. We previously characterized the
role of the capsular polysaccharide in stimulating a proinﬂamma-
tory response in the liver and spleen of BALB/c mice associated
with wild type-speciﬁc elevations in histopathologic damage in
these tissues (Warawa et al., 2009). Splenic pathology is a hallmark
of clinical melioidosis (Laopaiboon et al., 2009), and it is therefore
a concern that SKH1 mice do not allow for a full study of the host
response to melioidosis in the spleen. SKH1 mice possess a retro-
viral leukemia virus which interrupts the hr gene resulting in the
autosomal recessive hairless phenotype, and have been reported to
possess altered subpopulations of naïve and memory T cells rela-
tive to other common mouse strains (Schaffer et al., 2010). While
symptoms of leukemia do not exhibit until mice reach adulthood,
it is possible that T cell sub-population alterations in 8-week-old
SKH1 mice lead to the lack of the host response triggering splenic
pathology. Thus, SKH1 mice represent an excellent model for the
study of pulmonary disease kinetics during B. pseudomallei infec-
tion, but caution should be taken if this strain is used to study the
host response in disseminated tissues.
Optical imaging strategies for the detection of B. pseudomallei
inmice appear to be limited to detection of pathogen speciﬁcally in
the lung. We estimated the level of detection of B. pseudomallei in
the lung to be 106.3–106.8 CFU in SKH1 mice, and 106.6–107.4 CFU
in BALB/c mice. At terminal disease, B. pseudomallei burdens do
not exceed 105 CFU in the liver or spleen of BALB/c or SKH1 mice
with the exceptionof the livers of BALB/c-infectedmicewhichmay
exceed 106 CFU. It is possible that some punctate visualization of
hepatic colonization may be detected during terminal disease, but
the ability to monitor disease kinetics in the liver or spleen during
murine melioidosis may not be achievable with optical diagnostic
imaging. Engineering of new B. pseudomallei strains that produce
higher levels of light may allow for limited detection in the spleen,
but it is likely that the close proximity of the liver to the lung,
the signiﬁcant pigmentation of the liver, and the relatively higher
pulmonary colonization rates may mask the hepatic signal. Some
strains of B. pseudomallei also exhibit altered organ colonization
patterns, such as the NCTC 13178 strain which does not colonize
the lung at high titer, even when delivered intranasally (Barnes and
Ketheesan, 2005). Similarly, the lux+ B. pseudomallei 08 strain did
not colonize the lung at high titer when introduced intranasally
(Owen et al., 2009), but it is unclear whether this is due to the
low delivery volume or low strain virulence, as discussed above.
Therefore not all B. pseudomallei strains may be amenable to bio-
luminescent engineering for the in vivo detection of pulmonary
disease.
Diagnostic imaging was used in this study to identify unique
patterns of bacterial expansion in the lungs of BALB/c and SKH1
mice. BALB/c mice were found to be associated with a bipha-
sic expansion while SKH1 mice were more typically associated
with a low initial rate of expansion prior to rapid exponential
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expansion. Net bacterial expansion in the lung can be affected by
several variables including: (i) variation in bacterial growth rates in
different host niches, (ii) host immune-mediated clearance of bac-
teria, and (iii) reduction of lung colonization due to dissemination
to other key sites of infection. Additional studies will be required
to characterize the contribution of each of these variables on the
biphasic expansion in BALB/c mice and lag expansion in SKH1
mice. Importantly, this study highlights how diagnostic imaging
can critically impact our understanding of how melioidosis pro-
gresses in the lung in a mouse strain speciﬁc manner. Respiratory
disease in the mouse model is typically very acute with symptoms
of lethal pneumonia presenting within 3–4 days post-infection.
The ﬁndings of this study suggest that use of arbitrary time des-
ignations to identify stages of disease (e.g., 24 h post-infection
designation of early disease)maynot allow formeaningful study of
host–pathogen interaction in vivo. Diagnostic imaging is therefore
a critically important tool to aid in high resolution deﬁnition of
host–pathogen interactions in the study of both host and pathogen
responses during infection.
A phenotype identiﬁed for the capsular polysaccharide
B. pseudomallei mutant in this study was the elevated coloniza-
tion of the URT during infection. The high degree of nasal cavity
colonization for both the wild type and capsule mutant strains
had been an unexpected observation, with the nasal cavity bacte-
rial burden exceeding that of the lung in the majority of instances
of diagnostic imaging. This ﬁnding suggests that the murine nasal
cavity is a primary colonization niche for B. pseudomallei delivered
by the i.n. route, while we have not found evidence to suggest that
clinical melioidosis is associated with similar URT carriage. The
reason for a potential difference between human and murine URT
carriage may be due to opportunistic colonization in mice due to
the high relative surface area, where mice have been reported to
have over 100-fold greater relative surface area than the human
nasal cavity (Warawa, 2010). Alternatively, normal resident ﬂora
speciﬁc to the human URT may outcompete B. pseudomallei in
interspecies competition, a reported phenomenon for other res-
piratory pathogens (Lysenko et al., 2005). Additional studies are
required to characterize the murine-speciﬁc tolerance for URT-
related melioidosis and the role of capsular polysaccharide in
directing elevated URT colonization, which may shed light on our
general understanding of B. pseudomallei colonization of mucosal
surfaces.
In conclusion,we have characterized the ﬁrst in vivo pulmonary
diagnostic imaging model of melioidosis using a fully virulent,
stable, bioluminescent strain of B. pseudomallei. We validated the
ability to detectB. pseudomallei in the lung of infectedmice in both
BALB/c and SKH1 mice, with the higher level of sensitivity being
achieved in SKH1 mice. Different patterns of bacterial expansion
in the lung were observed in the two mouse strains suggesting
that altered kinetics of host response and/or dissemination pro-
ﬁles may affect disease in these strains. We also identiﬁed the high
propensity forURT colonization byB. pseudomallei with the intact
capsular polysaccharide modulating the level of colonization of
the nasal cavity. These ﬁndings highlight the importance of using
diagnostic imaging to characterize in vivo models of melioidosis.
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